Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

Clinical trial NCT06514898 · RECRUITING

Trial details

NCT number: NCT06514898
Sponsor: University of Florida
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Group 3 Medulloblastoma Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma

Start date: 2025-05-05
Primary completion: 2027-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.